HLA_NN
binding_NN
characteristics_NNS
and_CC
generation_NN
of_IN
cytotoxic_JJ
lymphocytes_NNS
against_IN
peptides_NNS
derived_VBN
from_IN
oncogenic_JJ
proteins_NNS
._.

AIMS_NNS
AND_CC
BACKGROUND_NN
:_:
Structurally_RB
altered_JJ
proteins_NNS
-LRB-_-LRB-
derived_VBN
from_IN
chromosomal_JJ
translocations_NNS
or_CC
gene_NN
mutations_NNS
-RRB-_-RRB-
can_MD
be_VB
considered_VBN
tumor_NN
specific_JJ
antigens_NNS
and_CC
represent_VB
an_DT
attractive_JJ
target_NN
for_IN
a_DT
T-cell_NN
mediated_JJ
response_NN
._.

T_NN
lymphocytes_NNS
recognize_VBP
antigens_NNS
in_IN
the_DT
form_NN
of_IN
peptides_NNS
bound_VBN
to_TO
HLA-molecules_NNS
._.

MATERIALS_NNS
AND_CC
METHODS_NNS
:_:
Peptides_NNS
derived_VBN
from_IN
oncogenic_JJ
proteins_NNS
were_VBD
screened_VBN
for_IN
the_DT
presence_NN
of_IN
HLA_NN
binding_NN
motifs_NNS
;_:
actual_JJ
binding_NN
were_VBD
evaluated_VBN
by_IN
HLA_NN
stabilization_NN
experiments_NNS
using_VBG
transfectants_NNS
and_CC
specific_JJ
anti-HLA_JJ
antibodies_NNS
._.

Specific_JJ
lymphocytes_NNS
were_VBD
induced_VBN
by_IN
in_FW
vitro_FW
peptide_NN
sensitization_NN
and_CC
screened_VBN
by_IN
thymidine_NN
uptake_NN
or_CC
cellular_JJ
cytotoxic_JJ
assays_NNS
._.

RESULTS_NNS
:_:
We_PRP
identified_VBD
peptides_NNS
derived_VBN
from_IN
EWS\/FLI_NN
-1_CD
fusion_NN
protein_NN
and_CC
from_IN
mutated_VBN
K-RAS_NN
protein_NN
-LRB-_-LRB-
encompassing_VBG
respectively_RB
the_DT
fusion_NN
point_NN
and_CC
the_DT
mutation_NN
at_IN
position_NN
12_CD
-RRB-_-RRB-
that_WDT
showed_VBD
binding_NN
motif_NN
for_IN
HLA-Cw_NNP
\*_NNP
0702_CD
and_CC
HLA-A3_NN
respectively_RB
._.

The_DT
actual_JJ
binding_NN
of_IN
these_DT
peptides_NNS
was_VBD
analyzed_VBN
in_IN
a_DT
stabilization_NN
assay_NN
._.

We_PRP
detected_VBD
binding_NN
for_IN
the_DT
EWS\/FLI_NN
-1_CD
peptide_NN
and_CC
for_IN
5_CD
RAS_NN
peptides_NNS
-LRB-_-LRB-
1_CD
wild_JJ
type_NN
and_CC
4_CD
mutated_VBN
-RRB-_-RRB-
._.

The_DT
effect_NN
of_IN
temperature_NN
,_,
beta_NN
2-microglobulin_NN
-LRB-_-LRB-
beta_NN
2-m_NN
-RRB-_-RRB-
and_CC
fetal_JJ
calf_NN
serum_NN
-LRB-_-LRB-
FCS_NN
-RRB-_-RRB-
on_IN
the_DT
binding_NN
and_CC
the_DT
stability_NN
of_IN
the_DT
HLA\/peptide_NN
complex_NN
was_VBD
studied_VBN
._.

A_DT
low_JJ
temperature_NN
-LRB-_-LRB-
26_CD
degrees_NNS
C_NN
-RRB-_-RRB-
increased_VBD
the_DT
binding_NN
both_DT
in_IN
HLA-A3_NN
and_CC
HLA-Cw_NNP
\*_NNP
0702_CD
,_,
while_IN
FCS_NN
reduced_VBD
it_PRP
._.

beta_NN
2-m_NN
increased_VBD
the_DT
binding_NN
to_TO
the_DT
HLA-A3_NN
molecule_NN
but_CC
did_VBD
not_RB
influence_VB
the_DT
binding_NN
to_TO
the_DT
HLA-Cw_NNP
\*_NNP
0702_CD
._.

The_DT
stability_NN
of_IN
already_RB
formed_VBN
complexed_VBN
was_VBD
somewhat_RB
different_JJ
in_IN
the_DT
HLA-A3_NN
and_CC
HLA-Cw_NN
\*_NN
0702_CD
system_NN
:_:
both_DT
were_VBD
more_RBR
stable_JJ
at_IN
26_CD
degrees_NNS
C_NN
than_IN
at_IN
37_CD
degrees_NNS
C_NN
but_CC
while_IN
the_DT
beta_NN
2-m_NN
and_CC
FCS_NN
did_VBD
not_RB
influence_VB
the_DT
stability_NN
of_IN
the_DT
HLA-A3_NN
\/_:
peptide_NN
complex_NN
,_,
they_PRP
seemed_VBD
to_TO
cause_VB
opposite_JJ
effects_NNS
in_IN
the_DT
HLA-Cw_JJ
\*_NN
0702_CD
system_NN
-LRB-_-LRB-
beta_NN
2-m_NN
stabilized_NN
and_CC
FCS_NN
destabilized_VBD
the_DT
complex_NN
-RRB-_-RRB-
._.

Finally_RB
,_,
we_PRP
were_VBD
able_JJ
to_TO
generate_VB
a_DT
specific_JJ
CD8_NN
+_CC
CTL_NN
line_NN
against_IN
a_DT
K-RAS_NN
mutated_JJ
peptide_NN
._.

CONCLUSIONS_NNS
:_:
Although_IN
binding_NN
motifs_NNS
and_CC
actual_JJ
HLA_NN
binding_NN
can_MD
be_VB
detected_VBN
in_IN
several_JJ
cases_NNS
,_,
the_DT
generation_NN
of_IN
a_DT
cellular_JJ
response_NN
is_VBZ
infrequent_JJ
,_,
confirming_VBG
that_IN
HLA_NN
binding_NN
is_VBZ
necessary_JJ
but_CC
not_RB
sufficient_JJ
to_TO
obtain_VB
an_DT
in_FW
vitro_FW
response_NN
._.

Further_JJ
optimization_NN
of_IN
culture_NN
conditions_NNS
,_,
type_NN
of_IN
Antigen_NN
Presenting_NN
Cells_NNS
-LRB-_-LRB-
APC_NN
-RRB-_-RRB-
,_,
peptides_NNS
,_,
use_NN
of_IN
stabilizers_NNS
like_IN
beta_NN
2-m_NN
are_VBP
still_RB
needed_VBN
._.

